RESMED INC — Director's Dealing 2010

Nov 29, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-24

Reporting Person: PENDARVIS DAVID (Sr. VP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-24	ResMed Common Stock	M	35000	$15.52	Acquired	60725.12	Direct
2010-11-24	ResMed Common Stock	S	35000	$32.534	Disposed	25725.12	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-11-24	ResMed Common Stock Options	$15.52	M	35000	Disposed	2015-11-20	ResMed Common Stock (35000)	Direct

Footnotes

F1: Represents date options first become available.

F2: This transaction was executed in multiple trades at prices ranging from $32.50-$32.608. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issure or the security holder of the issuer.